Literature DB >> 12633142

Insights into the diagnosis and treatment of lysosomal storage diseases.

David A Wenger1, Stephanie Coppola, Shu-Ling Liu.   

Abstract

Lysosomal storage diseases (LSDs) are a group of genetic disorders that result from defective lysosomal metabolism or export of naturally occurring compounds. Signs and symptoms are variable both within and between disorders depending on the location and extent of storage. Many patients develop neurologic symptoms that become obvious from the newborn period to adulthood. Diagnosis of suspected patients can usually be made by measuring the activity of an enzyme or concentration of a metabolite in easily obtained tissue samples. Based on the considerable diagnostic experience of our laboratory, we aid the physician in selecting the appropriate tests to perform. Hematopoietic stem cell transplantation and enzyme replacement therapy are already available or in clinical trials for a number of LSDs. Early diagnosis is critical, especially since those patients who are treated before significant symptoms arise have the best chance for a positive outcome.

Entities:  

Mesh:

Year:  2003        PMID: 12633142     DOI: 10.1001/archneur.60.3.322

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  17 in total

Review 1.  Young onset dementia.

Authors:  E L Sampson; J D Warren; M N Rossor
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

2.  Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI.

Authors:  Sean Turbeville; Helen Nicely; J Douglas Rizzo; Tanya L Pedersen; Paul J Orchard; Mitchell E Horwitz; Edwin M Horwitz; Paul Veys; Carmem Bonfim; Amal Al-Seraihy
Journal:  Mol Genet Metab       Date:  2010-10-25       Impact factor: 4.797

Review 3.  Glycosphingolipidoses: beyond the enzymatic defect.

Authors:  Annick Raas-Rothschild; Irene Pankova-Kholmyansky; Yaacov Kacher; Anthony H Futerman
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

4.  Monitoring autophagy in lysosomal storage disorders.

Authors:  Nina Raben; Lauren Shea; Victoria Hill; Paul Plotz
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 5.  Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging.

Authors:  Alexei Terman; Tino Kurz; Marian Navratil; Edgar A Arriaga; Ulf T Brunk
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

6.  Towards a selected reaction monitoring mass spectrometry fingerprint approach for the screening of oligosaccharidoses.

Authors:  John Sowell; Tim Wood
Journal:  Anal Chim Acta       Date:  2010-12-07       Impact factor: 6.558

7.  Burden of lysosomal storage disorders in India: experience of 387 affected children from a single diagnostic facility.

Authors:  Jayesh Sheth; Mehul Mistri; Frenny Sheth; Raju Shah; Ashish Bavdekar; Koumudi Godbole; Nidhish Nanavaty; Chaitanya Datar; Mahesh Kamate; Nrupesh Oza; Chitra Ankleshwaria; Sanjeev Mehta; Marie Jackson
Journal:  JIMD Rep       Date:  2013-07-13

Review 8.  Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders.

Authors:  Bradley C Nelson; Sherin I Hashem; Eric D Adler
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

9.  Preimplantation diagnosis of a lysosomal storage disorder by in situ enzymatic activity: 'proof of principle' in acid sphingomyelinase-deficient mice.

Authors:  A Butler; S C Henderson; R E Gordon; A Dagan; S Gatt; E H Schuchman
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

10.  Enzymatic Screening and Diagnosis of Lysosomal Storage Diseases.

Authors:  Chunli Yu; Qin Sun; Hui Zhou
Journal:  N Am J Med Sci (Boston)       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.